Refine
Has Fulltext
- yes (4)
Is part of the Bibliography
- yes (4)
Document Type
- Journal article (3)
- Doctoral Thesis (1)
Language
- English (4)
Keywords
- Activation (1)
- Adenocarcinomas (1)
- Beta-catenin (1)
- C-RAF (1)
- E-cadherin (1)
- Gene-expression (1)
- Human lung-cancer (1)
- In-vivo (1)
- Induced senescence (1)
- K-RAS (1)
- Kinase pathway (1)
- Metastasis (1)
- Model (1)
- P53 (1)
- VEGF (1)
- activation (1)
- airway (1)
- basal cell (1)
- clara cell (1)
- epithelial-cells (1)
- epithelium (1)
- gene expression (1)
- in vivo (1)
- inflammation (1)
- injury (1)
- kinase (1)
- lung cancer (1)
- lung-cancer (1)
- mouse models (1)
- obstructive pulmonary-disease (1)
- pathway (1)
- protein (1)
- renewal (1)
- somatic mutations (1)
- stem cells (1)
Steps involved in the progression of non-small cell lung cancer (NSCLC) to metastasis are poorly understood. Expression of oncogenic C-RAF in lung epithelial cells has yielded a model for non-small cell lung cancer (NSCLC). The induced adenomas are characterised by high genomic stability, a lack of tumor progression and pronounced cell-cell contacts raising the question whether disruption of E-cadherin complexes would promote progression to metastasis. Two genetic approaches were used to evaluate the role of adherens junctions in a C-RAF driven mouse model for NSCLC: conditional ablation of the Cdh1 gene and expression of dominant negative (dn) E-cadherin. Disruption of E-cadherin function caused massive formation of intratumoral vessels that was reversible in the early phase of induction. Vascularized tumors grew more rapidly, developed invasive fronts and gave rise to micrometastasis. ß-catenin was identified as a critical effector of E-cadherin disruption leading to up-regulation of angiogenic inducers (VEGF-A and VEGF-C) in mouse and human lung tumor cell lines. In vivo, lung tumor cells with disrupted E-cadherin expressed ß-catenin target genes of endodermal and other lineages suggesting that reprogramming may be involved in metastatic progression.